author-photo

Robert Olie

Janssen-Cilag

11

Papers

41

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice

2018 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (10)
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study

2017 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (12)
Outcome of first salvage therapy for multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, observational, non-interventional EMMOS study

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Frontline induction therapy for multiple myeloma (MM) in real-world clinical practice: Third interim analysis of the multinational, observational EMMOS study (NCT01241396)

2015 Haematologica
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study

2015 Hematology
Show All
- Source
- Cite
- Save
Citations (9)
Frontline therapy for multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, non-interventional, observational EMMOS study

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (2)
Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Effects of single-agent bortezomib (btz) as post-transplant consolidation on multiple myeloma (MM)-related bone disease: first results from a multicenter, randomized phase 2 study

2014
Show All
- Source
- Cite
- Save
Citations (0)